Air Purification Devices Distributed by UK Company, KSG Health, Are Proven to Be 99.999% Effective Against COVID
KSG Health, a UK importer and distributor of Genano air purification units, are delighted to share the fact that the systems have been independently...
Imagio Opto-Acoustic Imaging for Breast Lesions
Seno’s Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology. The Center...
New MRI head coil technology completes first trial
Product design consultancy Wideblue has congratulated its client MR CoilTech on successfully completing the first trial of a novel high-density radiofrequency (RF) head coil...
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
BONE THERAPEUTICS, the cell therapy company addressing unmet medical needs in orthopaedics and other diseases, today announces it has treated the first patient for...
Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced the close of a Series BB...
Study shows potential of remote electrical neurmodulation for children’s migraines
Theranica, a prescribed digital therapeutics company developing electroceuticals for migraine and other pain conditions, has announced that a new peer-reviewed study demonstrates the potential of remote...
Study Validates NuVasive X360 Approach
NuVasive, the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the...
Episurf Medical Reaches Milestone of 900 Implants
Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for...
Philips, BioIntelliSense to receive US funding for early detection of Covid-19 symptoms
Royal Philips and BioIntelliSense are set to receive about $2.8m funding from the US Department of Defense (DoD) to validate BioIntelliSense’s FDA-cleared BioSticker device...